In this regard, our findings on the role of the NAD+ salvage pathway in CD8 bTN cell induction adds a crucial piece to the metabolic puzzle being investigated. Targeting NAD+ salvage metabolism by inhibiting its rate limiting enzyme NAMPT has been previously shown to reduce effector T cell function in the tumor microenvironment (18, 21). This evidence concerns the gene CD8A and neoplasm.